155 related articles for article (PubMed ID: 36824931)
1. The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR
McClory SE; Bardhan O; Rome KS; Giles JR; Baxter AE; Xu L; Gimotty PA; Faryabi RB; Wherry EJ; Pear WS; Jordan MS
bioRxiv; 2023 Feb; ():. PubMed ID: 36824931
[TBL] [Abstract][Full Text] [Related]
2. The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR
McClory SE; Bardhan O; Rome KS; Giles JR; Baxter AE; Xu L; Gimotty PA; Faryabi RB; Wherry EJ; Pear WS; Jordan MS
Cell Rep; 2023 Aug; 42(8):112905. PubMed ID: 37527035
[TBL] [Abstract][Full Text] [Related]
3. Trib1 regulates T cell differentiation during chronic infection by restraining the effector program.
Rome KS; Stein SJ; Kurachi M; Petrovic J; Schwartz GW; Mack EA; Uljon S; Wu WW; DeHart AG; McClory SE; Xu L; Gimotty PA; Blacklow SC; Faryabi RB; Wherry EJ; Jordan MS; Pear WS
J Exp Med; 2020 May; 217(5):. PubMed ID: 32150623
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
5. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
[TBL] [Abstract][Full Text] [Related]
6. Divergent clonal differentiation trajectories of T cell exhaustion.
Daniel B; Yost KE; Hsiung S; Sandor K; Xia Y; Qi Y; Hiam-Galvez KJ; Black M; J Raposo C; Shi Q; Meier SL; Belk JA; Giles JR; Wherry EJ; Chang HY; Egawa T; Satpathy AT
Nat Immunol; 2022 Nov; 23(11):1614-1627. PubMed ID: 36289450
[TBL] [Abstract][Full Text] [Related]
7. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.
Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH
Front Immunol; 2021; 12():648420. PubMed ID: 34589081
[TBL] [Abstract][Full Text] [Related]
8. PD-1/CTLA-4 Blockade Leads to Expansion of CD8
Bufe S; Zimmermann A; Ravens S; Prinz I; Buitrago-Molina LE; Geffers R; Woller N; Kühnel F; Talbot SR; Noyan F; Manns MP; Wedemeyer H; Hardtke-Wolenski M; Jaeckel E; Davalos-Misslitz AC
Liver Cancer; 2023 Jun; 12(2):129-144. PubMed ID: 37325488
[TBL] [Abstract][Full Text] [Related]
9. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
[TBL] [Abstract][Full Text] [Related]
10. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
Balança CC; Salvioni A; Scarlata CM; Michelas M; Martinez-Gomez C; Gomez-Roca C; Sarradin V; Tosolini M; Valle C; Pont F; Ferron G; Gladieff L; Vergez S; Dupret-Bories A; Mery E; Rochaix P; Fournié JJ; Delord JP; Devaud C; Martinez A; Ayyoub M
JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33332284
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
12. Effector Th1 cells under PD-1 and CTLA-4 checkpoint blockade abrogate the upregulation of multiple inhibitory receptors and by-pass exhaustion.
Horzum U; Yanik H; Taskiran EZ; Esendagli G
Immunology; 2022 Dec; 167(4):640-650. PubMed ID: 36053975
[TBL] [Abstract][Full Text] [Related]
13. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
14. [Stimulatory and inhibitory signaling pathways of the T cell-APC interaction and the effect of TLR agonists on APCs].
Kürten CHL; Deuß E; Lei YL; Höing B; Kramer B; Lang S; Ferris RL; Kansy BA
HNO; 2020 Dec; 68(12):916-921. PubMed ID: 33128107
[TBL] [Abstract][Full Text] [Related]
15. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
16. Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer.
Wang Y; Wang C; Qiu J; Qu X; Peng J; Lu C; Zhang M; Zhang M; Qi X; Li G; Hua K
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288463
[TBL] [Abstract][Full Text] [Related]
17. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.
Blackburn SD; Shin H; Freeman GJ; Wherry EJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15016-21. PubMed ID: 18809920
[TBL] [Abstract][Full Text] [Related]
18. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
Front Immunol; 2020; 11():576743. PubMed ID: 33519801
[TBL] [Abstract][Full Text] [Related]
19. Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8
Chen CY; Ueha S; Ishiwata Y; Shichino S; Yokochi S; Yang D; Oppenheim JJ; Ogiwara H; Deshimaru S; Kanno Y; Aoki H; Ogawa T; Shibayama S; Matsushima K
Cancer Immunol Res; 2021 Oct; 9(10):1214-1228. PubMed ID: 34344641
[TBL] [Abstract][Full Text] [Related]
20. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
